Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.7100 (3.76%) ($15.7100 - $15.7100) on Wed. Oct. 20, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.03% (three month average) | RSI | 34 | Latest Price | $15.7100(3.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -6.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) IBB(46%) ARKG(45%) ARKK(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.515% in a week (0% probabilities). VIXM(-40%) VXX(-28%) UNG(-15%) USO(-11%) TLT(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.515% (StdDev 3.03%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $4.59(-70.78%) | Resistance Level | $16.73 | 5 Day Moving Average | $15.29(2.75%) | 10 Day Moving Average | $16.11(-2.48%) | 20 Day Moving Average | $16.73(-6.1%) | To recent high | -12.4% | To recent low | 30.9% | Market Cap | $1.167b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |